- Home
- JOUT vs IMMP Comparison
JOUT vs IMMP Comparison
Compare JOUT & IMMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JOUT
- IMMP
- Stock Information
- Founded
- JOUT 1970
- IMMP 1987
- Country
- JOUT United States
- IMMP Australia
- Employees
- JOUT N/A
- IMMP N/A
- Industry
- JOUT Recreational Games/Products/Toys
- IMMP Biotechnology: Pharmaceutical Preparations
- Sector
- JOUT Consumer Discretionary
- IMMP Health Care
- Exchange
- JOUT Nasdaq
- IMMP Nasdaq
- Market Cap
- JOUT 341.7M
- IMMP 304.0M
- IPO Year
- JOUT N/A
- IMMP N/A
- Fundamental
- Price
- JOUT $33.76
- IMMP $1.91
- Analyst Decision
- JOUT
- IMMP Buy
- Analyst Count
- JOUT 0
- IMMP 2
- Target Price
- JOUT N/A
- IMMP $8.50
- AVG Volume (30 Days)
- JOUT 59.0K
- IMMP 95.6K
- Earning Date
- JOUT 01-31-2025
- IMMP 02-27-2025
- Dividend Yield
- JOUT 3.94%
- IMMP N/A
- EPS Growth
- JOUT N/A
- IMMP N/A
- EPS
- JOUT N/A
- IMMP N/A
- Revenue
- JOUT $592,846,000.00
- IMMP $2,563,302.00
- Revenue This Year
- JOUT $2.07
- IMMP N/A
- Revenue Next Year
- JOUT $11.94
- IMMP $47.79
- P/E Ratio
- JOUT N/A
- IMMP N/A
- Revenue Growth
- JOUT N/A
- IMMP 9.59
- 52 Week Low
- JOUT $29.98
- IMMP $1.66
- 52 Week High
- JOUT $50.00
- IMMP $3.34
- Technical
- Relative Strength Index (RSI)
- JOUT 48.15
- IMMP 40.99
- Support Level
- JOUT $32.15
- IMMP $2.00
- Resistance Level
- JOUT $33.75
- IMMP $2.05
- Average True Range (ATR)
- JOUT 1.31
- IMMP 0.09
- MACD
- JOUT -0.11
- IMMP -0.02
- Stochastic Oscillator
- JOUT 41.82
- IMMP 2.78
About JOUT Johnson Outdoors Inc.
Johnson Outdoors Inc is a manufacturer and marketer of branded seasonal, outdoor recreation products used for fishing from a boat, diving, paddling, hiking and camping. The company has four operating segment: Fishing, Camping, Watercraft Recreation, and Diving. It generates maximum revenue from the Fishing segment which produces and markets products under different brands such as Minn Kota electric motors for quiet trolling or primary propulsion, marine battery chargers and shallow water anchors; Humminbird sonar and GPS equipment for fish finding, navigation and marine cartography; and Cannon downriggers for controlled-depth fishing. Geographically, it derives a majority of revenue from the United States and also has a presence in Europe, Canada, and other regions.
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.